See the difference! Customize Seeking Alpha:
Sign in or join
Seeking Alpha
Home
The Macro View
Stocks & Sectors
Global Markets
ETFs
Investing Ideas
News, Data, Transcripts
Achillion Pharmaceuticals Inc. (ACHN)
(
)
Quotes
Dashboard
Chart
Historical Prices
Options
Analysis
Articles
Instablogs
StockTalks
Sentiment
Comments
News & PR
Market Currents
Buzz
Twitter: ACHN
Coverage
Top Authors
Cramer
Top Analysts
Business Intelligence
Transcripts
Events
Key Developments
Earnings
History & Projected
Consensus
Peer Earnings
Filings
SEC Filings
Annual Report
Ownership
Major Holders
Insider Trades
Insider Sentiment
Index Membership
Short Interest
Financials
Income Statement
Balance Sheet
Cash Flow
Company
Wikipedia Profile
Officers & Directors
Executive Comp
52wk high:
52wk low:
EPS:
PE:
Dividend:
Yield:
Market Cap:
Exchange:
Analysis - Latest Articles
China Biotech Week in Review: New Investments in Life Science
ChinaBio Today
•
Feb 08
•
Comment!
Achillion Pharma Out-Licensed China Rights for HIV, Hepatitis Treatment
ChinaBio Today
•
Feb 04
•
Comment!
Recent Dividend Hikes May Point to a Return to Normalcy
Alan Brochstein
•
Jan 24
•
5 Comments
FDA Calendar Updates: Achillion Pharma, Roche, Genzyme, Protalix, Shire
Mike Havrilla
•
Jul 31
•
Comment!
In Search of Healthcare Diamonds in the Rough
Mike Havrilla
•
Jan 13
•
2 Comments
Looking for Laggards After the Latest Market Rally
Mike Havrilla
•
Dec 09
•
3 Comments
More articles on ACHN »
Sentiment
What advice would you give to
ACHN?
123 characters left
What's your view of ACHN?
Make sure you include ACHN
140 characters left
|
Settings
Geoffreygc40
: Analysis of the Hepatitis drug that
ACHN
has in development:
ACHN
-1625
http://bit.ly/5yUssE
Mon, Jan 11, 2010
Mike Havrilla
: $
ACHN
/ Achillion Pharma / Reports proof-of-concept / Phase 1 data for
ACH
-1625 / anti-viral hepatitis
C
/
http://tinyurl.com/ycxhwmu
Wed, Dec 16, 2009
More StockTalks on ACHN »